rose.pharmamedtechbi.comHBW Insight | Commercial News | Cosmetics and Dietary Supplements :: HBW Insight

Acccess Token : Refresh Token : Entitlement Claim : We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy . By continuing to use the website, you consent to our use of cookies. HBW Insight is part of Pharma Intelligence UK Limited This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group. Informa ToggleMy View Other Products: In Vivo | Medtech Insight | Pink Sheet | Scrip | Generics Bulletin Other Products: In Vivo | Pink Sheet | Generics Bulletin Scrip | Medtech Insight | Report StoreStart Trial Sign In This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183 Printed By UsernamePublicRestriction Existing Subscriber? Sign in to continue reading. Sign In New to HBW Insight? Start a free trial today! Free Trial Health Business Marketing Regulation/Legislation Beauty Business Marketing Regulation/Legislation Wellness Business Marketing Regulation/Legislation Featured Topics Sustainability Rx-to-OTC Switch Cannabis/CBD Get To Know COVID-19 Small Business Matters Digital Health & AI Market Intelligence Data Interviews Podcasts Trademarks MoreMeet the Team RSS Feeds PDF Library Partnered Content FAQs & Help Contact Us Customer Services Help Subscribe Advertising Ask the Analyst Feedback My View Outlook 2024 Annual Industry Ranking And Forecast VIEW NOW Featured Stories Bookmark 30 Apr 2024 News ‘Cowboy Companies’ To Be Named, Shamed And Fined Under EU Supply Chain Directive By David Ridley Bookmark 29 Apr 2024 Analysis Supreme Court To Hear RICO Complaint Against CBD Firms As Hemp Regulation Remains AWOL By Malcolm Spicer Bookmark 29 Apr 2024 Analysis Beauty Firms Should Draft AI Use Policies, Even If They Don’t Plan To Use AI – Attorney By Eileen Francis Spotlight On 2024 16 Jan 2024 Analysis Consumer Health In 2024: ‘Switch Power,’ ‘Reframing Sustainability’ And Meeting Household Budgets By HBW Insight Team Views from industry leaders and experts on the biggest trends, challenges and opportunities facing consumer health in the new year. Prescription To OTC Switch Digital Health Association Focus In 2024: Self-Care, Sustainability And Prospects For Political ‘Reorientation’ Wellness In 2024: Expect Growth Fueled By Digital And AI-Powered Personalization Beauty In 2024: Driving Industry Growth And Innovation In An Increasingly Regulated World Advertising Law In 2024: Attorneys Tuning In For ‘Clean Beauty,’ ‘Dark Patterns’ Developments Latest Articles Haleon ‘Tight Lipped’ On US Eroxon Roll Out, But Analysts Say 2024 Launch Possible Nature’s Sunshine Looks For Cost Savings To Rise Over Long Haul Switching To Sustainable Energy PCPC Board Chair; EL Companies Taps New Head Of Key Brands; La Prairie CEO; Beauty Exec News EU Asks Companies And Experts To Weigh In On Vitamin E Max Level US Health And Wellness People News: Nutrabolt, Ghost, MyFitnessPal, Med-Bev, Ahara, More Former FTC Member Harbour Appointed To Radicle Science’s Advisory Board UPC/EAN Twilight: Consumer Goods Industry Sets Gaze On 2D Barcode ‘Sunrise’ Bayer Takes Its Aspirin-Branded Digital CVD Screening Tool To Saudi Arabia People On The Move: Appointments At Alliance, Perrigo, Zambon US FDA Clearance For Masimo’s Stork Wakes Up OTC Baby Monitoring Technology Competition ASA Files: It’s Not Just What You Say, But How You Say It Unilever’s ‘Gray T-Shirt’ Advertising Overstated Degree Advanced 72H Sweat Prevention – NAD US Competition To Connect Obesity Drug Patients With Supplements Attracts Retail Heavyweights DSM-Firmenich Flags Fish Oil Supplement Shortage Over The Counter: Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta Coty’s Social Media Investments Have CoverGirl, Rimmel On More Lips, Minds And Receipts Opill Launch Delivers For Perrigo While Growing Pains Slow Overall First-Quarter Results Kenvue Cutting Staff 4% After Year Apart From J&J AESGP: Despite MDR Failures, ‘Complete Overhaul’ Not Needed US FDA Inspectors, Product Centers Working Closer Together Ahead Of ORA Reorg Without Additional Funding, US FDA’s Inspections In Jeopardy – Regulatory Affairs Chief Herbalife’s Rising Digital Platform Floats All Boats Other Than Marketing To GLP-1 Patients Beauty Packaging Producers Facing Tedious EPR Work Should Consider Software Solutions Need Advice About Advisory Committees, US FDA? Try Having Some FDA Advisory Committee Reform: Does Listening Session Suggest No Major Near-Term Changes? See All Advertisement Global Policy, Regulation & Law EU Asks Companies And Experts To Weigh In On Vitamin E Max Level By Tom Gallen Manufacturers of dietary supplements and other interested parties have until 9 June to respond to tolerable upper intake levels set by EFSA for vitamin E based on a review of available scientific literature on associated adverse events. US FDA Clearance For Masimo’s Stork Wakes Up OTC Baby Monitoring Technology Competition By Malcolm Spicer Masimo receives US regulatory clearance for Stork OTC baby monitoring system six months after Owlet received first clearance for its Dream Sock following a regulatory stumble which halted sales of a previous device, Smart Sock, in 2021. ASA Files: It’s Not Just What You Say, But How You Say It By David Ridley Infirst gets rapped by UK ad authority, ASA, for implying its lipid-based ibuprofen brand Flarin is more effective than other ibuprofen products. The lesson: think about whether any emphasis given to certain words within a claim, or whether the positioning of a claim within an ad, is likely to affect the overall take-home message, advises Advercheck. Unilever’s ‘Gray T-Shirt’ Advertising Overstated Degree Advanced 72H Sweat Prevention – NAD By Eileen Francis I Am Sweating But Nothing On My Armpits!” and other no-sweat advertising claims made for Unilever’s Degree Advanced 72H antiperspirant products were challenged by P&G in the National Advertising Division forum. See All Digital Health & AI Bayer Takes Its Aspirin-Branded Digital CVD Screening Tool To Saudi Arabia By David Ridley Bayer Consumer Health’s recently established Precision Health unit launches its Aspirin Heart Risk Assessment tool in Saudi Arabia. Developed in partnership with British medtech firm Huma Therapeutics, Bayer is planning to roll out the digital tool to other countries in the Middle East and also Latin America. US Competition To Connect Obesity Drug Patients With Supplements Attracts Retail Heavyweights By Malcolm Spicer Vitamin Shoppe announces Whole Health Rx telehealth services offering supplements for GLP-1 patients and access to doctors for prescribing the drugs a week after GNC said it was first major retailer to establish an entire section dedicated to assisting GLP-1 users.” Herbalife’s Rising Digital Platform Floats All Boats Other Than Marketing To GLP-1 Patients By Malcolm Spicer Direct seller reports Q1 sales up 1% to $1.3bn but net sales off 17.1% from year-ago period to $24.3m. Its distributor ranks jumped so far in 2024, particularly in China, where changes were made in the past year including new company leadership. AI News: Lauder Expands Microsoft Partnership; Prose Beauty; Supply Chain Software; More By Ryan Nelson The Estee Lauder Companies’ expanding use of artificial intelligence includes an internal-facing generative AI chatbot to help users efficiently navigate and further leverage ELC’s proprietary and extensive database of product and claim data.” Meanwhile, Prose Beauty is leveraging AI to market personalized skin and hair products at scale, and Vagaro to provide salons and spas with instantly crafting polished communications, such as service and...